A Meta-Analysis Evaluating the Incidence of Bleeding Events With Intravenous Defibrotide Treatment Outside the Veno-Occlusive Disease/Sinusoidal Obstruction Syndrome Setting

Defibrotide is approved to treat hepatic veno-occlusive disease/sinusoidal obstruction syndrome (VOD/SOS) with renal/pulmonary dysfunction following hematopoietic cell transplantation (HCT) in adult and pediatric patients in the United States, and to treat severe hepatic VOD/SOS post-HCT in adult an...

Descripción completa

Detalles Bibliográficos
Autores principales: Tappe, William, Aggarwal, Saurabh, Topaloglu, Ozlem, Iacobelli, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372611/
https://www.ncbi.nlm.nih.gov/pubmed/32687402
http://dx.doi.org/10.1177/1076029620935202

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7372611/
https://www.ncbi.nlm.nih.gov/pubmed/32687402
http://dx.doi.org/10.1177/1076029620935202

Ejemplares similares